Impact of Frailty on Long-Term Outcomes in Patients After Acute Kidney Injury.
BACKGROUND
Frailty is increasingly recognized as a determinant of adverse outcomes after acute illness, reflecting diminished physiological reserve and vulnerability to stressors. However, its long-term prognostic significance following dialysis-requiring acute kidney injury (AKI-D) remains uncertain.
We aimed to examine the association between frailty and long-term outcomes in patients with acute kidney disease (AKD) after recovery from AKI-D.
METHODS
We did a nationwide cohort study using Taiwan’s National Health Insurance Research Database. Adults aged 18 years or older who were admitted with dialysis-requiring acute kidney injury between 1 January 2015 and 30 September 2022 and remained dialysis-free for 90 days after discharge were included.
Follow-up began 90 days after discharge and continued until the occurrence of an outcome of interest or 31 December 2023. The primary outcomes were all-cause mortality, major adverse cardiovascular events (MACE) and major adverse kidney events (MAKE).
RESULTS
Of 18 525 survivors after AKI (mean age 68.3 years, 58.8% men), frailty was classified as fit (3768, 20.3%), mild (8443, 45.6%) or moderate-severe (6314, 34.1%) using a claims-based multimorbidity frailty index.
Over a median follow-up of 2.35 years, mild frailty was not significantly associated with all-cause mortality compared with the fit group (aHR, 1.06; 95% CI, 0.99-1.13), whereas moderate to severe frailty conferred a higher risk (aHR, 1.17; 95% CI, 1.09-1.25). For MACE, mild frailty was associated with an adjusted subdistribution hazard ratio (sHR) of 1.21 (95% CI, 1.08-1.34) and moderate to severe frailty with an sHR of 1.37 (95% CI, 1.22-1.53), compared with the fit group.
For MAKE, the respective sHR were 1.07 (95% CI, 1.00-1.15) and 1.13 (95% CI, 1.04-1.22). In longitudinal analysis of the 2016-2018 subgroup, the proportion of fit individuals remained stable over five years, while the prevalence of moderate to severe frailty declined, primarily due to a progressive increase in cumulative mortality from 22% to 55%.
CONCLUSION
Frailty was highly prevalent among survivors after dialysis-requiring AKI and showed a clear, dose-related association with subsequent death, cardiovascular events and kidney events.
These findings support the incorporation of frailty assessment into post-AKI care to enable risk stratification and guide targeted interventions aimed at improving long-term outcomes.
